Real-World Treatment Patterns of Older Adults with Locally Advanced SCCHN Using SEER-Medicare

被引：0
|
作者：
Zhou, S. Q. [1 ]
Ng, C. [2 ]
Wang, R. [2 ]
Gasior, G. [2 ]
Schrader, D. [2 ]
Baliga, S. [3 ]
Fox, D. [2 ]
机构：
[1] Genesis Res, Hoboken, NJ USA
[2] Genentech Inc, South San Francisco, CA USA
[3] Ohio State Univ, Columbus, OH USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3392
引用
收藏
页码：E637 / E637
页数：1
相关论文
共 50 条
  • [41] Patterns and predictors of rehabilitation therapy among older patients with advanced cancer admitted to nursing homes: A SEER-Medicare analysis.
    Xu, Huiwen
    Mohile, Supriya Gupta
    Culakova, Eva
    Bowblis, John R.
    Intrator, Orna
    Jensen-Battaglia, Marielle
    Lin, Po-Ju
    Loh, Kah Poh
    Yang, Shuhan
    Hile, Elizabeth
    Lund, Jennifer Leigh
    Mustian, Karen Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Prognosis of Older Adults with Chronic Lymphocytic Leukemia By Comorbidity and Frailty: A SEER-Medicare Cohort Study
    Duchesneau, Emilie D.
    McNeill, Annie M.
    Tyczynski, Jerzy E.
    Schary, William
    Lund, Jennifer L.
    BLOOD, 2020, 136
  • [43] Real-world treatment (tx) patterns, cost, and overall survival (OS) by line of therapy among patients (pt) with mantle cell lymphoma (MC): A SEER-Medicare (SM) analysis.
    Keating, Scott J.
    Rege, Sanika
    McBride, Ali
    Shah, Ruchit
    Qian, Joyce
    Chirikov, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 19 - 19
  • [44] Time at home among older adults with acute myeloid leukemia based on treatment intensity: A SEER-Medicare analysis.
    Richardson, Daniel R.
    Zhou, Xi
    Jensen, Christopher Edward
    Reeder-Hayes, Katherine Elizabeth
    Lund, Jennifer Leigh
    Baggett, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Outcomes Between Concurrent Cisplatin Versus Cetuximab in Locally Advanced Oropharyngeal Carcinoma: A SEER-Medicare Analysis
    Amini, A.
    Eguchi, M.
    Jones, B. L.
    Stokes, W. A.
    Lanning, R. M.
    McDermott, J.
    Bhatia, S.
    Raben, D.
    Bradley, C. J.
    Karam, S. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1335 - 1335
  • [46] Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data
    Ajani, J. A.
    Leung, L.
    Kanters, S.
    Singh, P.
    Kurt, M.
    Kim, I.
    Pourrahmat, M. -m.
    Friedman, H. S.
    Navaratnam, P.
    Reardon, G.
    ESMO OPEN, 2024, 9 (11)
  • [47] Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis
    Pal, Sumanta K.
    Ghate, Sameer R.
    Li, Nanxin
    Swallow, Elyse
    Peeples, Miranda
    Zichlin, Miriam L.
    Perez, Jose Ricardo
    Agarwal, Neeraj
    Vogelzang, Nicholas J.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (04) : E573 - E582
  • [48] Real-world survival outcomes and prognostic factors among patients receiving first targeted therapy for advanced renal cell carcinoma: a SEER-medicare database analysis
    Vogelzang, Nicholas
    Pal, Sumanta
    Ghate, Sameer
    Li, Nanxin
    Swallow, Elyse
    Peeples, Miranda
    Zichlin, Miriam
    Perez, Jose R.
    Agarwal, Neeraj
    BJU INTERNATIONAL, 2016, 118 : 15 - 15
  • [49] A SEER-MEDICARE DATA ANALYSIS OF ELDERLY GLIOBLASTOMA PATIENTS: TREATMENT PATTERNS, OUTCOMES AND COST
    Burton, Eric
    Ugiliweneza, Beatrice
    Woo, Shiao
    Skirboll, Stephen
    Boakye, Maxwell
    NEURO-ONCOLOGY, 2014, 16
  • [50] Sensitivity of Diagnosis and Treatment Codes in the Identification of Adults with Acute Lymphoblastic Leukemia in SEER-Medicare
    Katz, Aaron J.
    Chia, Victoria M.
    Danese, Mark D.
    Duryea, Jennifer
    Kelsh, Michael A.
    Lubeck, Deborah P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 575 - 576
12345